Comprehensive pharmacologic therapy for treatment of obesity
OwnerMartin C. Hinzinventor
Life of this patent
Estimating the term…
Abstract
The comprehensive pharmacologic therapy for treatment of obesity is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for brief and long durations which may be 12 months or more. The preferred procedure involves the administration of drugs in combination which are identified as: Citalopram (Celexa) and Phentermine; Citalopram (Celexa) and Diethylpropion; Citalopram (Celexa), Phentermine, and Diethylpropion. In addition nutritional supplementation such as a multivitamin, 5-Hydroxytryptophan, vitamin B6, vitamin C, Tyrosine, Calcium, and Lysine may be used to enhance the performance of the weight loss treatment program.
Claims14
A method to facilitate weight loss for a patient not suffering from depression, said method comprising:
- A. administration of Citalopram;
- B. administration of Diethylpropion;
- and
- C. administration of Vitamin B6 wherein said Citalopram and said Diethylpropion are administered in an effective therapeutic range to effectuate weight loss said effective therapeutic range comprising:
- i. the administration of 10 mg of said Citalopram each day for a period of 6 days followed by the administration of a daily dosage of between 10 mg and 80 mg of said Citalopram:
- and
- ii. the administration of 25 mg of said Diethylpropion each day for said period of 6 days followed by the administration of a daily dosage of between 25 mg and 75 mg of said Diethylpropion until a target weight for said patient is obtained.
A method to facilitate weight loss for a patient not suffering from depression, said method comprising:
- A. administration of a biologically active enantiomer of Citalopram;
- B. administration of Diethylpropion;
- and
- C. administration of Vitamin B6 where said biologically active enantiomer of Citalopram and said Diethylpropion are administered in an effective therapeutic range to effectuate weight loss said effective therapeutic range comprising:
- i. the administration of 10 mg of said biologically active enantiomer of Citalopram each day for a period of 6 days followed by the administration of a daily dosage of between 10 mg and 80 mg of said biologically active enantiomer of Citalopram;
- and
- ii. the administration of 25 mg of said Diethylpropion each day for said period of 6 days followed by the administration of a daily dosage of between 25 mg and 75 mg of said Diethylpropion until a target weight for said patient is obtained.
Dependencies are inferred from the claim text.